-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SIR-2446 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SIR-2446 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SIR-2446 in Alzheimer's Disease Drug Details:SIR-2446 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NBTXR-3 in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NBTXR-3 in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NBTXR-3 in Hypopharyngeal Cancer Drug Details: NBTXR-3 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NBTXR-3 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NBTXR-3 in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NBTXR-3 in Laryngeal Cancer Drug Details: NBTXR-3 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NBTXR-3 in Oral Cavity (Mouth) Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NBTXR-3 in Oral Cavity (Mouth) Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NBTXR-3 in Oral Cavity (Mouth) Cancer Drug Details: NBTXR-3 is...
-
Product Insights
Janssen Pharma – Beerse Geothermal Power Plant – Flanders
Equip yourself with the essential tools needed to make informed and profitable decisions with our Janssen Pharma - Beerse Geothermal Power Plant - Flanders report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...
-
Sector Analysis
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Report Overview PsA is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and the sacroiliac joints of the pelvis. Clinical diagnosis and assessment of PsA involve a combination of patient history, physical examination, laboratory tests, and imaging studies. The goal of diagnosis and assessment is to identify the presence and extent of joint involvement, assess...
-
Company Profile
UroGen Pharma Ltd – Company Profile
UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd, is a biopharmaceutical company that develops novel medicines to treat cancer indications and urologic diseases. It is headquartered in Ra'Anana, Israel.
Add to Basket -
Company Profile
Eisai Inc – Company Profile
Eisai Inc (Eisai America), a subsidiary of Eisai Co Ltd, is a healthcare company that discovers, develops, and markets pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Banzel for adjunctive treatment, and Dayvigo for the insomnia. The company’s research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory, and immunological reaction. Eisai America established partnerships and collaborations with global companies such as Pfizer, Janssen Pharmaceutica Inc, Elan Pharma International Ltd, and...
Add to Basket -
Thematic Analysis
Digital Marketing Trends in Inflammatory Bowel Disease
Digital Marketing Trends in Inflammatory Bowel Disease Report Overview AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 9.3 million visitors from March 2022 to February 2023. This was followed by AbbVie’s Rinvoq.com and Takeda’s Entyvio.com. The highest proportion of traffic originated from direct sources, followed by organic. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Takeda spent on digital display advertising (DDA) for Entyvio.com. The digital marketing...